Business Wire

DirectSens’ Market-Leading LactoSens ® Biosensor Technology Acquired by Kerry Group P.L.C.

Share

DirectSens, a pioneer in next generation biosensor technology, announces the acquisition of its LactoSens® technology by Kerry Group, a global leader in taste and nutrition. The acquisition of LactoSens® reflects DirectSens’ success in developing end-to-end biosensor solutions and represents a move by Kerry Group to complement its offering in lactase enzymes. As an indispensable analytical tool, LactoSens® will work alongside Kerry Group’s ingredient solutions, enabling a more integrated offering for food manufacturers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241105399369/en/

LactoSens®, Industry Gold Standard Biosensor Kit. Developed and manufactured by DirectSens in Vienna, AUSTRIA, © DirectSens GmbH 2024

“We’re excited to bring LactoSens® into Kerry Group’s portfolio to add a new element to our offering, as we fully integrate LactoSens® into our broader solutions for the food and beverage industry.” — Ronan Moloney, Vice President Enzymes, Kerry Group

Proven track record with global success of LactoSens®

Since its introduction, 8 years ago, LactoSens® has become the industry’s preferred solution for fast, accurate, and cost-effective lactose detection. It is widely used in food and beverage manufacturing, enabling producers to meet stringent regulatory requirements while running their processes efficiently. Its real-time analysis capabilities give manufacturers a competitive edge, solidifying LactoSens® as a market leader.

DirectSens’ Market-Leading Enzyme Engineering and BioSensor technology

For DirectSens, this acquisition proves the market value of its biosensor technology. “This deal underscores the quality of our biosensor technology and manufacturing capabilities. We will continue to execute on our vision to develop and deliver fast and precise biosensor solutions for key analytes to the global marketplace.” said Dr. Christoph Sygmund, CEO of DirectSens.

As the trusted contract manufacturer, DirectSens will continue to ensure the high-quality production of LactoSens®, upholding the product’s established market reputation. This acquisition reinforces DirectSens’ position as a key innovator in the biosensor industry. Excited by this success, the DirectSens team, with its dedicated and passionate individuals, is looking forward to continuing to create new products such as OatSens®, LactaZyme®, XPressGT®, and to foster collaborations with valued partners.

About DirectSens

DirectSens was founded in 2013 in Vienna, Austria, as a biotech company. Specializing in the development of biosensors, DirectSens provides innovative bioanalytical solutions. Press release.

About Kerry Group

Kerry Group is a world leader in taste and nutrition, serving the food, beverage, and pharmaceutical markets. With a commitment to innovation, Kerry Group helps its customers create sustainable, delicious, and healthy products for consumers worldwide. See related Press release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241105399369/en/

Contacts

Gina Gazzari office@directsens.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CoStar Group Partnership to Enhance Market Insights and Drive Growth for New Client Bray Fox Smith22.1.2025 17:32:00 CET | Press Release

CoStar Group, Inc. (NASDAQ: CSGP) (“CoStar Group,” “we” or “our”), a leading provider of online real estate marketplaces, information, and analytics in the property markets, has announced a new client partnership with Bray Fox Smith, a London-based commercial property consultancy focusing on Office Agency and Multi-Sector Investment and Development. This partnership will allow Bray Fox Smith to leverage CoStar’s unrivalled commercial real estate data and analytics platform to drive business growth and deliver enhanced advisory services. With access to CoStar’s extensive insights on property values, market conditions, occupancy levels, and availability, Bray Fox Smith’s team will be well-equipped to uncover a greater number of new opportunities and better understand value in the market. “At CoStar Group, we are dedicated to providing our forward-looking clients with industry-leading insights and tools they need to excel in the commercial real estate market,” said Andy Florance, Founder

Sia Unveils New Name and Refreshed Branding22.1.2025 17:17:00 CET | Press Release

This evolution reflects the firm’s commitment to optimism and unwavering focus on helping clients achieve the best possible outcomes in their transformation journeys. The refreshed brand is more than just a new look—it’s a renewed purpose. The move is designed to inspire fresh perspectives, grounded in the belief that what you can get out of change depends on how you approach it. Sia is presenting its consultants as ‘Optimists for change’, emphasizing its core business of helping clients to profit from opportunity and to overcome challenges. CEO, Matthieu Courtecuisse, shares: “As AI, climate change and cyber threats bring new challenges and opportunities, Sia is well positioned to help our clients respond. We are a next generation consultancy, born digital, augmented by data science, enhanced by creativity and driven by responsibility". “Our revised name is simpler and more memorable for us and for our clients. Our positioning of ‘Optimists for change’ reflects our ‘Can do’ attitude.

Rimini Street Announces Rimini Protect ™ Advanced Hypervisor Security for VMware, Nutanix and All Other Linux-Based Hypervisors, Powered by Vali Cyber ® , to Safeguard Against Ransomware and Other Vulnerabilities22.1.2025 15:00:00 CET | Press Release

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, the leading third-party support provider for Oracle, SAP and VMware software, today announced the general availability of Rimini Protect™ Advanced Hypervisor Security (AHS), an exclusive solution powered by proven Vali Cyber® AI/ML security technology. The Rimini Protect AHS solution leverages these innovative capabilities that are already protecting mission-critical hypervisor infrastructure, including US military VMware deployments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250122401764/en/ Rimini Street Announces Rimini Protect™ Advanced Hypervisor Security for VMware, Nutanix and All Other Linux-Based Hypervisors, Powered by Vali Cyber®, to Safeguard Against Ransomware and Other Vulnerabilities (Graphic: Business Wire) The Rimini Protect AHS solution combines Vali Cyber technology with Rimini Str

Qualcomm Schedules First Quarter Fiscal 2025 Earnings Release and Conference Call22.1.2025 15:00:00 CET | Press Release

Qualcomm Incorporated (NASDAQ: QCOM) today announced that it will publish the Company’s financial results for its first quarter fiscal 2025 on Wednesday, February 5, 2025, after the close of the market on the Company’s Investor Relations website, at https://investor.qualcomm.com/financial-information. The earnings release will also be furnished to the Securities and Exchange Commission (SEC) on a Form 8-K, which will be available on the SEC website at http://www.sec.gov. Qualcomm will host a conference call to discuss its first quarter fiscal 2025 results which will be broadcast live on February 5, 2025, beginning at 1:45 p.m. Pacific Time (PT) at https://investor.qualcomm.com/news-events/investor-events/default.aspx. An audio replay will be available at https://investor.qualcomm.com/news-events/investor-events/default.aspx and via telephone following the live call for 30 days thereafter. To listen to the replay via telephone, U.S. callers may dial (877) 660-6853 and international call

Novotech Releases Comprehensive Report on Oncolytic Virus Therapy22.1.2025 14:05:00 CET | Press Release

Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel therapeutics, has released its latest report, Oncolytic Virus Therapy: Global Clinical Trial Landscape 2024. This comprehensive whitepaper analyzes the evolving landscape of oncolytic virus therapies (OVT), providing critical insights into this transformative approach to cancer treatment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250122884484/en/ Oncolytic virus therapies utilize genetically modified or naturally occurring viruses to selectively target tumor cells and stimulate immune responses. This dual mechanism is creating new possibilities in oncology and other therapeutic areas. Key Highlights: Global Trial Landscape: Asia-Pacific leads with 40% of OVT clinical trials, followed closely by North America and Europe, refle

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye